BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 24504735)

  • 1. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
    Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
    Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
    PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
    Li K; Ching D; Luk FS; Raffai RL
    Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
    Wan W; Liu Q; Lionakis MS; Marino AP; Anderson SA; Swamydas M; Murphy PM
    Cardiovasc Res; 2015 Jun; 106(3):478-87. PubMed ID: 25858253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
    Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.
    Hu YW; Zhao JY; Li SF; Huang JL; Qiu YR; Ma X; Wu SG; Chen ZP; Hu YR; Yang JY; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):87-101. PubMed ID: 25265644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.
    Wan W; Lim JK; Lionakis MS; Rivollier A; McDermott DH; Kelsall BL; Farber JM; Murphy PM
    Circ Res; 2011 Aug; 109(4):374-81. PubMed ID: 21680896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
    Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
    J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.